Author

Andrew David Redfern

Observed names: A D Redfern, A Redfern, A. Redfern, A.D. Redfern, AD Redfern, Andrew D Redfern, Andrew D. Redfern, Andrew REDFERN, Andrew Redfern, Andy Redfern, Redfern, A.; id_orcid 0000-0001-6728-8713, Redfern, AD, Redfern, Andrew
ORCID: 0000-0001-6728-8713
Observed ORCID: 0000-0001-6728-8713
OpenAlex ID: A5004957581
2019 · Elizabeth D. Williams, Dingcheng Gao, et al. · Nature reviews. Cancer · 451
2013 · Keith M. Giles, Felicity C. Kalinowski, et al. · Molecular Cancer Therapeutics · 155
2006 · Esme C. Hatchell, Shane M. Colley, et al. · Molecular Cell · 132
2013 · Andrew D. Redfern, Shane M. Colley, et al. · Proceedings of the National Academy of Sciences · 129
2020 · Bedrich L. Eckhardt, Yuan Cao, et al. · Cancer Research · 79
2018 · Andrew D. Redfern, Lisa J. Spalding, et al. · Clinical & Experimental Metastasis · 64
2019 · Jessica A. Kretzmann, Cameron W. Evans, et al. · Chemical Science · 59
2025 · Erik W. Thompson, Andrew D. Redfern, et al. · Nature Reviews Clinical Oncology · 55
2019 · Anabel Sorolla, Edina Wang, et al. · Nanomedicine Nanotechnology Biology and Medicine · 51
2021 · Mohit Kumar Jolly, Ryan J. Murphy, et al. · Cells Tissues Organs · 48
2014 · Nina Wressnigg, Maikel V. W. van der Velden, et al. · Clinical and Vaccine Immunology · 47
Works count: 217
Citation count: 5,941
H-index: 31
I10-index: 49
Year
Topic
Type